Research programme: muscarinic M1 receptor agonists - Eli LillyAlternative Names: LY 593093
Latest Information Update: 22 Apr 2009
At a glance
- Originator Eli Lilly
- Class Small molecules
- Mechanism of Action Muscarinic M1 receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Cognition disorders
Most Recent Events
- 22 Apr 2009 No development reported - Preclinical for Cognition disorders in USA (unspecified route)
- 07 Apr 2003 Preclinical trials in Cognition disorders in USA (unspecified route)